Long-term efficacy and safety of larotrectinib in patients with TRK fusion-positive lung cancer.

9109Background: Neurotrophic tyrosine receptor kinase (NTRK) gene fusions have been identified as oncogenic drivers in a diverse array of tumor types including lung cancer. Larotrectinib is a first...